CMR-Derived Myocardial Strain May Reflect Advanced Graft Injury Rather Than Acute Rejection After Heart Transplantation
- 1Pediatric Research Center, University of Helsinki and Helsinki University Hospital
Abstract
Aims Cardiac magnetic resonance imaging (CMR) T1 and T2 mapping accurately detect acute heart transplant rejection, but the diagnostic value of CMR-derived strain imaging remains uncertain, particularly for right ventricular strain. Data incorporating donor-derived cell-free DNA (dd-cfDNA) into a composite reference standard are limited. We evaluated the diagnostic accuracy of CMR-derived left and right ventricular strain and ejection fraction for detecting acute rejection in pediatric and adult heart transplant recipients. Methods and results Blinded analysis of 1.5T CMR studies was performed in pediatric and adult heart transplant recipients 1-24 months post-transplant and during five additional rejection episodes 3-14 years post-transplant. Left and right ventricular strain and ejection fraction were quantified using semi-automated post-processing. Acute rejection was defined using a composite reference standard comprising endomyocardial biopsy (EMB), clinical assessment, and dd-cfDNA. Diagnostic performance was assessed using cut-offs from receiver operator characteristic analysis. Among 214 CMR studies in 58 patients, 13 cases of acute rejection were identified. Diagnostic performance for detecting acute rejection was highest for pediatric right ventricular longitudinal strain (AUC 0.782, 95% CI 0.565-0.999), although imprecise due to data heterogeneity. All other cardiac functional parameters demonstrated limited discrimination in both pediatric and adult patients (AUC 0.536-0.739). Models based on individual rejection indicators (EMB, clinical assessment, and dd-cfDNA) also showed poor diagnostic accuracy. Conclusion CMR-derived strain and ejection fraction showed limited diagnostic value for detecting acute rejection. Routine strain analysis therefore appears to have limited utility for rejection surveillance, with abnormalities primarily reflecting more advanced graft injury.
Related
- Dynamic kinetics of graft-derived cell-free DNA and personalized tacrolimus target ranges for acute rejection monitoring in pediatric liver transplantation
- Post Heart Transplantation Immunosuppression and Rejection: What the General Cardiologist Needs to Know
- Phenotyping Antibody-mediated Rejection Without Detectable Donor-specific Antibodies 8 d After Heart Transplantation: A Case Study
- Late-onset Acute Cellular Rejection after Lung Transplantation Triggered by a Fluctuation in the Tacrolimus Trough Level Which Was Successfully Treated with Steroid Pulse Therapy
- Prospective evaluation of donor-derived cell-free DNA for noninvasive detection of acute rejection in an Asian heart transplant population.
BibTeX
@misc{taipale2026cmrderived,
title = {{CMR-Derived Myocardial Strain May Reflect Advanced Graft Injury Rather Than Acute Rejection After Heart Transplantation}},
author = {M. Taipale and M. Pentikainen and L. Martelius and A. Mutka and S. Kytola and M. Kankainen and J. I. Peltonen and S. Syrjala and A. Lahtiharju and J. Lommi and T. Jahnukainen and K. Lemstrom and T. Ojala},
howpublished = {medRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.10.26360075},
url = {https://www.medrxiv.org/content/10.64898/2026.08.10.26360075v3},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - CMR-Derived Myocardial Strain May Reflect Advanced Graft Injury Rather Than Acute Rejection After Heart Transplantation
AU - M. Taipale
AU - M. Pentikainen
AU - L. Martelius
AU - A. Mutka
AU - S. Kytola
AU - M. Kankainen
AU - J. I. Peltonen
AU - S. Syrjala
AU - A. Lahtiharju
AU - J. Lommi
AU - T. Jahnukainen
AU - K. Lemstrom
AU - T. Ojala
PY - 2026
DA - 2026/08/10
PB - medRxiv
DO - 10.64898/2026.08.10.26360075
UR - https://www.medrxiv.org/content/10.64898/2026.08.10.26360075v3
AB - Aims Cardiac magnetic resonance imaging (CMR) T1 and T2 mapping accurately detect acute heart transplant rejection, but the diagnostic value of CMR-derived strain imaging remains uncertain, particularly for right ventricular strain. Data incorporating donor-derived cell-free DNA (dd-cfDNA) into a composite reference standard are limited. We evaluated the diagnostic accuracy of CMR-derived left and right ventricular strain and ejection fraction for detecting acute rejection in pediatric and adult heart transplant recipients. Methods and results Blinded analysis of 1.5T CMR studies was performed in pediatric and adult heart transplant recipients 1-24 months post-transplant and during five additional rejection episodes 3-14 years post-transplant. Left and right ventricular strain and ejection fraction were quantified using semi-automated post-processing. Acute rejection was defined using a composite reference standard comprising endomyocardial biopsy (EMB), clinical assessment, and dd-cfDNA. Diagnostic performance was assessed using cut-offs from receiver operator characteristic analysis. Among 214 CMR studies in 58 patients, 13 cases of acute rejection were identified. Diagnostic performance for detecting acute rejection was highest for pediatric right ventricular longitudinal strain (AUC 0.782, 95% CI 0.565-0.999), although imprecise due to data heterogeneity. All other cardiac functional parameters demonstrated limited discrimination in both pediatric and adult patients (AUC 0.536-0.739). Models based on individual rejection indicators (EMB, clinical assessment, and dd-cfDNA) also showed poor diagnostic accuracy. Conclusion CMR-derived strain and ejection fraction showed limited diagnostic value for detecting acute rejection. Routine strain analysis therefore appears to have limited utility for rejection surveillance, with abnormalities primarily reflecting more advanced graft injury.
ER -